Metformin and early pregnancy?

Fertility and Sterility

Volumn 86, Issue 5, 2006, Pages 1551-1552

  Vanky, Eszter ^a   Hjorth Hansen, Henrik ^b   Carlsen, Sven M ^b  

^a Institute of Laboratory Medicine   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

CLINICAL PRACTICE; CLINICAL TRIAL; DRUG SAFETY; FETOMATERNAL TRANSFUSION; FETUS DISTRESS; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; LETTER; MORBIDITY; OBESITY; OVARY POLYCYSTIC DISEASE; PREGNANCY OUTCOME; PRESCRIPTION; PRIORITY JOURNAL; PROGENY; RANDOMIZATION;

ADOLESCENT; ADULT; FEMALE; HUMANS; INFANT, NEWBORN; INFERTILITY, FEMALE; MALE; METFORMIN; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 33750186105     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.05.009     Document Type: Letter

References (4)

1. Thatcher S.S., and Jackson E.M. Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. Fertil Steril 85 (2006) 1002-1009
2. Vanky E., Salvesen K.A., Heimstad R., Fougner K.J., Romundstad P., and Carlsen S.M. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 19 (2004) 1734-1740
3. Glueck C.J., Goldenberg N., Wang P., Loftspring M., and Sherman A. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 19 (2004) 510-521
4. Vanky E., Zahlsen K., Spigset O., and Carlsen S.M. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 83 (2005) 1575-1578